Editorial: Settling the UGDP controversy.
D000284:Administration, Oral; D001699:Biometry; D002318:Cardiovascular Diseases / Q000401:mortality; D003365:Costs and Cost Analysis; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005380:Financing, Government; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D007258:Informed Consent; D012109:Research Support as Topic; D013997:Time Factors; D014044:Tolbutamide / Q000009:adverse effects; D014481:United States
D007004:Hypoglycemic Agents; D014044:Tolbutamide